INDUSTRIALISATION
INJECTION
DUAL CHAMBER
FORMULATION
PFS
WEARABLES
ALL INJECTION
OCULAR
ORAL
RESPIRATORY
PULMONARY
NASAL
ALL RESPIRATORY
MORE
INTERVIEWS
EXPERT VIEWS
EARLY INSIGHTS
COMPANY LISTINGS
OUR AUTHORS
THE MAGAZINE
EVENTS
ED CALENDAR
CONTRIBUTE
MEDIA PACK
Subscribe
INDUSTRIALISATION
INJECTION
DUAL CHAMBER
FORMULATION
PFS
WEARABLES
ALL INJECTION
OCULAR
ORAL
RESPIRATORY
PULMONARY
NASAL
ALL RESPIRATORY
MORE
INTERVIEWS
EXPERT VIEWS
EARLY INSIGHTS
COMPANY LISTINGS
OUR AUTHORS
THE MAGAZINE
EVENTS
ED CALENDAR
CONTRIBUTE
MEDIA PACK
SEARCH
SEARCH
advanced search
INTERVIEW
INTERVIEW
Chris Baron
Aptar Pharma
The Transition to Lower-Global-Warming-Potential Propellants in pMDIs
Aptar Pharma’s Chris Baron discusses how the company has developed a new metering valve technology platform – ZEN30 Futurity™ – that is compatible with leading lower-GWP propellants. By collaborating with drug developers, regulators and the pMDI supply chain, Aptar Pharma aims to support the reduction of the CO
2
footprint of pMDIs while ensuring that the pharmaceutical industry’s strict regulatory requirements are met or exceeded.
INTERVIEW
Audrey Chardonnet
Aptar Pharma
Interview: Sustainability at the Heart of Aptar Pharma’s Expansion
Audrey Chardonnet discusses the centrality of sustainability to Aptar Pharma’s expansion strategy, going into detail on how, by improving its practices and investing in its infrastructure, the company works towards reducing the environmental impact of injectable drug delivery solutions manufacturing.
INTERVIEW
Pascal Halbherr
InnoMedica
Interview: Pharmapack Start-up Spotlight: InnoMedica Accelerating Trials with Novel Nanoparticle Filling
Pascal Halbherr discusses the InnoMedica's innovative nanocarrier filling technology platform, its impact on biotech and drug delivery, and the company’s bold vision for the future. InnoMedica, a Swiss biotech, is one of the 28 early-stage companies presenting cutting-edge innovations in Pharmapack Europe 2025’s Start-up Market.
INTERVIEW
Julien Storz
Aptar Pharma
INTERVIEW: PUREHALE
®
AND THE FUTURE OF FINE MIST DISPENSERS FOR UPPER AIRWAY TREATMENTS
Julien Storz and Giulia Mueller discuss the latest trends and treatment options available for upper airway conditions, along with the many benefits offered by Aptar Pharma’s advanced PureHale
®
systems to manufacturers.
INTERVIEW
Alastair Willoughby
Team Consulting
Pharmapack Preview: An INTERVIEW with ALASTAIR WILLOUGHBY
CPHI Milan this year included a key discussion led by Team Consulting’s Alastair Willoughby on “Understanding the Problem of Decarbonisation in Drug Delivery”; one of the industry’s critical challenges. These themes will be discussed in greater depth at Pharmapack Europe in Paris in January.
INTERVIEW
Scott Ariagno
EdgeOne Medical
INTERVIEW with Scott Ariagno, EdgeOne Medical
Scott Ariagno talks exclusively with ONdrugDelivery's Guy Furness about the role that contract development organisations play in the drug delivery industry ecosystem and how independent expertise can enable companies like EdgeOne Medical to troubleshoot and accelerate product development.
ROUNDTABLE
Stephen Perry
Kymanox
ROUNDTABLE: DISCUSSION ON ANTI-OBESITY TREATMENTS
Stephen M Perry, Mathias Romacker and Andreas Schneider tackle the subject of GLP-1s and related obesity-targeted injectable therapeutics and the enormous impact they are having and are expected still to have on drug delivery and the wider pharmaceutical sector.
INTERVIEW
Louise Righton
Bespak
Interview with Bespak’s Louise Righton & Benedicta Bakpa
An increasing global incidence of respiratory diseases, such as asthma and COPD, is driving demand for therapies. Simultaneously, greenhouse gas emissions continue to rise, so the pharma industry must consider how to produce much-needed nasally delivered and orally inhaled medicines whilst minimising environmental impact. Louise Righton and Benedicta Bakpa discuss the many different aspects involved in driving sustainability in inhaled drug delivery – and the next steps.
INTERVIEW
Glenn Svedberg
Nolato Group
INTERVIEW with GLENN SVEDBERG
Glenn Svedberg engages in a wide-ranging discussion around the role and importance of sustainability in the drug delivery industry, and how Nolato Group has approached implementing this critical aspect of the modern industry landscape. Mr Svedberg considers how sustainability factors play into the relationship between CDMOs like Nolato and pharma companies, the importance of materials and how to drive forward sustainability goals within pharma and drug delivery.
INTERVIEW
Dr Dean Minnock
Innovation Zed
Interview with DEAN MINNOCK
Guy Furness and Dean Minnock discuss Innovation Zed’s unique origin story and digital connectivity add-on for injection pens. They dive into the value of digital ecosystems in the drug delivery industry and look towards the future as the company prepares to launch its third-generation add-on technology – DOSE.
INTERVIEW
Eric Leven
Rip Road
Interview with Eric Leven, Rip Road
Guy Furness and Eric Leven discuss Rip Road’s work with SaMD applications, including the company's customisable platform for delivery device companion apps. Leven shares his thoughts on the potential of connectivity to enhance the patient experience of biologic therapies, based on years working in the digital space, as well as how far connected drug delivery has come and how far it has yet to go.
INTERVIEW
Reto Jost
Ypsomed
INTERVIEW: THE BENEFITS OF BEING AN EARLY ADOPTER OF SUSTAINABILITY PRINCIPLES
Reto Jost and Gabriel Kalbermatter talk exclusively with ONdrugDelivery's Guy Furness, discussing the progress Ypsomed has made in advancing its sustainability agenda, particularly the implementation of its ecodesign guideline, the benefits of being an early adopter of sustainability principles, how YpsoMate 5.5 mL has been designed from the ground up with sustainability in mind and where sustainability considerations currently fit into the wider pharma industry.
INTERVIEW
Dora Rio
SHL Medical
INTERVIEW with Dora Rio, Head of Sustainability, SHL Medical
Dora Rio discusses various aspects of SHL's approach to sustainability, including how it interacts with other players up and down the value chain, whether reusable or single-use devices are more sustainable and how SHL addresses sustainability concerns beyond CO
2
.
INTERVIEW
Henryk Badack
Vetter Pharma
SUSTAINABILITY PROGRAMMES: EVERY STEP COUNTS
Henryk Badack shares insights into the current state of sustainability in the pharma and biotech industry, how sustainability commitments vary between organisations and what companies can do to develop sustainability strategies that will last.
INTERVIEW
Dr Julie Suman
Aptar Pharma
Interview: EXPLORING NASAL CASTS IN NASAL DRUG DEVELOPMENT
Julie Suman discusses nasal casts, their development, applications and significance for nasal drug product development.
INTERVIEW
Dr Sandy Munro
Phillips Medisize
Interview with Sandy Munro, Vectura
In this exclusive interview with ONdrugDelivery’s Guy Furness, Sandy Munro, PhD, of Vectura discusses his extensive career, focused on respiratory drug delivery. He shares his insights into current trends within the industry, including the growth of biologics, systemic delivery via inhalation, the potential of mesh nebulisers and connectivity in clinical trials.
INTERVIEW
Natalia Servol
Unither Pharmaceuticals
INTERVIEW: UNITHER PHARMACEUTICALS’ INNOVATIVE APPROACH TO OPHTHALMIC MANUFACTURING
Natalia Servol shares insights into Unither Pharmaceutical’s preservative-free multidose technology. With a focus on addressing patient needs and meeting industry demands, the company offers a distinctive approach to sterile manufacturing in the ophthalmic sector.
INTERVIEW
Lilli Zakarija
EdgeOne Medical
Interview with Lilli Zakarija, EdgeOne Medical
Lilli Zakarija talks with Guy Furness about how EdgeOne Medical provides a critical service to companies undertaking drug delivery device development programmes, from small biotech start-ups all the way up to major pharmaceutical players. As part of this discussion, Ms Zakarija delves into the evolution of the drug delivery device industry over the past decades, some common pitfalls companies fall into during device development and what makes this sector such an exciting one to work in.
INTERVIEW
Dr Alexandre Fontayne
Unither Pharmaceuticals
Interview with Alexandre Fontayne, Unither Pharmaceuticals
Guy Furness and Alexandre Fontayne discusses Unither Pharmaceuticals' EuroJect
®
injection device, based on the company’s extensive experience with blow-fill-seal technology. Mr Fontayne covers the advantages of EuroJect
®
compared with traditional glass syringes and multidose vials, as well as touching on where Unither sees EuroJect
®
having an impact in the market
INTERVIEW
Dr Troels Keldmann
A SYMBIOTIC RELATIONSHIP BETWEEN DRUG DELIVERY DEVICE SYSTEMS AND PHARMA
Troels Keldmann discusses the significance of the drug delivery industry, its relationship to pharma, the challenges it faces and how the pharma industry is shaping the drug delivery device field.
INTERVIEW
Jeff Henderson
Vetter Pharma
INTERVIEW with Jeff Henderson
Jeff Henderson discusses the practice of outsourcing within the pharmaceutical industry. He considers factors that pharma and biopharma companies should consider when determining whether or not to outsource to a CDMO and many of the advantages that outsourcing can offer, especially to small- and medium-sized companies.
INTERVIEW
Claire Raynal-Olive
Aptar Pharma
Interview with Claire Raynal-Olive & Pierre-Yves Favennec
Claire Raynal-Olive and Pierre-Yves Favennec discuss the strategy and objectives of Aptar Pharma’s expansion programme of its global rubber component manufacturing, implementing advanced technology, increased capacity and local-for-local manufacturing capability.
INDUSTRIALISATION
Dr Dave Seaward
3P Innovation
AUTOMATING ASSEMBLY TO EXPEDITE TIME-TO-MARKET
Dave Seaward discusses how 3P innovation takes a holistic approach to solving the technical challenges encountered by its clients and looks for opportunities to enhance the final product, enable efficient processing and support commercially viable manufacturing.
INTERVIEW
Dr Doug Bryans
Bryllan
INTERVIEW: DOUG BRYANS, BRYLLAN & JOHN MERHIGE, CREDENCE
Douglas Bryans and John Merhige discuss the changing needs of drug developers around novel dual-chamber and ready-to-use drug delivery devices, capacity and the delivery of complete solutions from CDMOs and device developers, anchored around the recently announced partnership between Credence MedSystems and Bryllan to provide these critical services.
Prev
1
2
3
4
5
Next
Top
